Patients with loss-of-function mutations in the BTK gene present with X-Linked agammaglobulinemia (XLA), an inherited immunodeficiency marked by an almost complete arrest of B cell development at the pre-B cell stage in the BM and a near absence of peripheral B cells and circulating Ig (10, 11). Here, BTK is linked to Bruton-type agammaglobulinemia.